Table 4.
Prevalence of NAFLD and abnormal ALT, AST, and γ-GTP activities according to urinary bisphenol A levels
| Quartile 1 (n = 888) | Quartile 2 (n = 880) | Quartile 3 (n = 860) | Quartile 4 (n = 848) | P value | ||
|---|---|---|---|---|---|---|
| NAFLD | Actual number | 201 | 214 | 242 | 258 | 0.002 |
| Weighted frequency (95% CI) | 21.83 (18.42-25.68) | 22.14 (18.88-25.78) | 25.55 (21.64-29.90) | 29.18 (25.48-33.19) | ||
| Abnormal ALT | Actual number | 83 | 88 | 87 | 102 | 0.023 |
| Weighted frequency (95% CI) | 10.41 (8.22-13.11) | 12.27 (9.36-15.93) | 11.25 (8.80-14.27) | 15.34 (12.53-18.66) | ||
| Abnormal AST | Actual number | 110 | 82 | 91 | 10 | 0.872 |
| Weighted frequency (95% CI) | 12.24 (9.62-15.45) | 7.59 (5.67-10.09) | 9.99 (8.03-12.35) | 11.77 (9.45-14.58) | ||
| Abnormal γ-GTP | Actual number | 104 | 89 | 99 | 95 | 0.844 |
| Weighted frequency (95% CI) | 10.86 (8.54-13.72) | 9.29 (6.97-12.29) | 12.05 (9.42-15.29) | 10.31 (8.06-13.09) | ||
NAFLD nonalcoholic fatty liver disease, AST aspartate aminotransferase, ALT alanine aminotransferase, γ-GTP gamma-glutamyl transpeptidase